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Objective: Women diagnosed with gestational diabetes mellitus (GDM) remain at high risk of developing
type 2 diabetes mellitus in the future. The effectiveness of medical nutrition therapy (MNT) acting on
GDM is increasingly becoming noteworthy.
Materials and Methods: A retrospective cohort study involving 488 GDM cases was conducted. The
prepregnancy weight, weight changes during pregnancy, glucose levels, GDM management, follow-up,
and birth outcomes were recorded from 2008 to 2012.
Results: Overall, 62.91% of the women received MNT, with an increasing trend from 2008 to 2012
(p < 0.01). The fasting plasma glucose, 2-hour blood glucose, and weight gain at 28 weeks, 32 weeks, and
36 weeks as well as intrapartum were lower in the MNT group than in the non-MNT group. Total weight
gain during pregnancy and the rates of adverse events during pregnancy were lower in the MNT group
compared to the non-MNT group (all p < 0.05). Moreover, 92.2% of the participants in the MNT group had
a normal oral glucose tolerance test result, and the rate of exclusive breastfeeding within 4 months after
delivery was 54.4% in the MNT group; both were higher than those of the non-MNT group (66.3%,
p < 0.001; 29.3%, p < 0.05).
Conclusion: MNT can reduce the incidence of pregnancy complications, increase the exclusive breast-
feeding rate, and improve pregnancy outcomes.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Gestational diabetes mellitus (GDM) is deﬁned as glucose
intolerance that is ﬁrst detected during pregnancy. Shortly after
delivery, glucose homeostasis is restored to nonpregnancy levels,
but women diagnosed with GDM remain at high risk of devel-
oping type 2 diabetes mellitus (T2DM) in the future [1]. The as-
sociation between GDM and T2DM is important for the
elucidation of the causes of these disorders, and for the predictionnd Gynecology, ChinaeJapan
jing 100029, China.
bstetrics & Gynecology. Publishedand possible prevention or delay of T2DM in women. GDM has a
negative impact on pregnant women as well as fetal and neonatal
development. GDM causes maternal polyhydramnios, pregnancy-
induced hypertension syndrome, fetal macrosomia, deformities,
and stillbirths. GDM is also linked to apnea syndrome, hypogly-
cemia, hypocalcemia, and polycythemia in newborns. Long-term
exposure to intrauterine hyperglycemia increases the risks of
obesity, diabetes, and other metabolic syndromes in children [2].
Studies show that by managing blood sugar during pregnancy,
short- and long-term outcomes for the mother and children can
be signiﬁcantly improved [3]. A number of known risk factors for
GDM have become increasingly prevalent among pregnant Chi-
nese women: the average age of pregnant women is increasing,by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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dents in China, carried out in 2002, the prevalence of overweight
and obesity rose 39% and 97%, respectively, compared to the re-
sults of the previous survey conducted in 1992 [2]. Excessive body
weight gain during pregnancy is an independent risk factor for
GDM.
Medical nutrition therapy (MNT) is a key tool to manage GDM
and can positively inﬂuence pregnancy outcomes of mother and
child health [4,5]. The clinical manifestations of GDM are most
apparent during the mid and third trimesters of pregnancy and
include abnormally high blood glucose, and even diabetic ketoa-
cidosis [6,7]. In this stage, maternal nutritional needs reach their
peak, and the contradiction between glucose control and nutri-
tional needs is most pronounced [8]. MNT to manage GDM is
designed to guarantee nutritional needs during pregnancy while
achieving acceptable glucose control [9,10].
The China Medical Nutrition Therapy Guidelines for Diabetes
(2010) [11], edited by the Chinese Diabetes Society and the China
Medicine Doctor Association Nutrition Doctor Specialized Com-
mittee, is the ﬁrst diabetes MNT guideline published in China. It
focuses on evidence-based MNT, dietary recommendations, MNTof
diabetic complications, MNT workﬂow, and personalized MNT
programs for special situations, such as GDM, children with dia-
betes, and diabetes among the elderly.
A few studies about the status and effectiveness of MNT to
manage GDM in China had been published. We reviewed the
experience with regard to diagnosis of GDM and its management
through MNT among high-risk pregnant women in a hospital in
Beijing, China, in the period 2008e2012. We focused on pregnant
women's weight changes, blood glucose monitoring results,
adverse events during pregnancy, pregnancy outcomes, infant
feeding, and postpartum prognosis. The ﬁndings were then dis-
cussed with a view to establish a more rational and effective pre-
natal care model.
Methods
Study site, participants, and deﬁnitions
The retrospective cohort study focused on the register of high-
risk pregnancies, which was managed by the associated Depart-
ment of Clinical Nutrition and Obstetrics of the ChinaeJapan
Friendship Hospital (Beijing, China) during 2008e2012. The study
participants were high-risk pregnant women with GDM (a
singleton fetus), who had undergone regular pregnancy examina-
tion and have delivered a live-born baby.Womenwho had a history
of adverse pregnancy outcomes or multiple pregnancies were
excluded. The diagnostic criteria for GDM in the hospital were as
follows: positive 75-g oral glucose tolerance test (OGTT) result in
gestational Weeks 24e28 as described by the American Diabetes
Association 2004 [12] and the Guidelines for Clinical Diagnosis and
Treatment Recommendations for GDM (2007, Draft) promulgated
in China during 2008e2011 [13e16]. The following cutoffs were
observed: fasting plasma glucose (FPG), 5.3 mmol/L; 1-hour blood
glucose (1hBG), 10 mmol/L; and 2-hour blood glucose (2hBG),
8.6 mmol/L. Patients with one item reaching or exceeding the above
threshold values were diagnosed to have GDM. In 2012, the Inter-
national Association of Diabetic Pregnancy Study Group 2010 and
the professional standards for diagnosis of GDM issued by the
Ministry of Health based on the American Diabetes Association
2011 were introduced in the hospital, and the following cutoffs
were observed: FPG, 5.1 mmol/L; 1hBG, 10 mmol/L; and 2hBG,
8.5 mmol/L. Patients with at least one of these diagnostic factors
reaching or exceeding the above threshold values were diagnosed
with GDM.Aside from the maternal monitoring records archived in the
Medical Records room and the high-risk pregnancy documentation
archived at the Department of Prevention and Healthcare, nutri-
tional treatment records archived at the Department of Clinical
Nutritionwere also reviewed.Written informed consent for the use
of health data for research purposes was obtained from all partic-
ipants when they accepted the pregnancy monitoring. The study
protocol has been revised by the Ethical Committee of ChinaeJapan
Friendship Hospital, and verbal consent was obtained from the
patients (IRB 2015-110).
Management of high-risk pregnant women
The Department of Prevention and Healthcare keeps the ﬁles
detailing the status and management of pregnant women with
GDM and their fetuses. The documentation also tracks the inci-
dence of common complications during pregnancy and their
management (gestational hypertension, pregnancy vulvovaginal
candidiasis, etc.), use of insulin during pregnancy, adverse preg-
nancy outcomes (preterm birth, premature rupture of membranes
and amniotic ﬂuid abnormalities, neonatal hypoglycemia, etc.),
mode of delivery (cesarean section or vaginal delivery), birth
weight, neonatal blood glucose levels, postpartum infant feeding,
and OGTT reexamination results. A complete set of data was ac-
quired, with missing data completed by consulting complementary
medical records. Home visits or telephone follow-up interviews
were conducted to identify data not available in the hospital.
Medical nutrition therapy
Pregnant women with GDM were routinely advised to receive
MNT counseling in the associated Department of Clinical Nutrition
and Obstetrics, where trained nutritionists provide individualized
MNT programs for pregnant women with conﬁrmed GDM. Nutri-
tionists ﬁlled in the general prepregnancy record form upon the
initial diagnosis of GDM and referral to them; these data included
height, prepregnancy body weight, medical history and family
history, and the prepregnancy body type {calculated as the pre-
pregnancy body mass index (BMI) based on the 2002 standards
issued by theWorking Group on Obesity in China, International Life
Science Institute [17]}. They also established daily energy re-
quirements and calorie supply proportions of the three major nu-
trients in accordance with the China Medical Nutrition Therapy
Guideline for Diabetes (2010) based on the prepregnancy body type,
gestational age at the time of GDM diagnosis, increase in body
weight during pregnancy, blood pressure, and lipid outcomes [11].
They then provided suggestions with regard to the type of food,
speciﬁcally quantifying the recommended intake for each type of
food. They also assisted in the selection of foods among similar food
types via the “method of food exchange serving” to diversify the
patients' diets while ensuring a balanced intake of all necessary
nutrients. Finally, they suggested reasonably arranged meal times
and foods in each meal based on blood glucose monitoring data,
recommended staple foods with low glycemic index values, and
emphasized eating many small meals to reduce each meal's gly-
cemic load. Regular postprandial exercise was also recommended.
Pregnant women were encouraged to obtain private fast blood
glucose meters, kitchen scales, and body weight scales for self-
monitoring of ﬁnger-prick blood glucose, food intake, and body
weight at home. The monitoring forms (3 d/wk) focused on food
contents in each meal, intake, fasting glucose, 2-hour postprandial
blood glucose, and fasting body weight measured in the morning
for timely adjustment of the therapy on follow-up appointments.
The ﬁrst follow-up visit was scheduled within 2 weeks since the
initial diagnosis of GDM and the start of MNT. Compliance was
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2e4 weeks were suggested depending on the patient's compliance.
Themonitoring formwas to be ﬁlled in prior to each follow-up visit,
and nutritionists assessed whether nutrient intakewas appropriate
andwhether the bodyweight increasewas reasonable based on the
reported data.
Statistical analysis
All data were analyzed using the SPSS 17.0 software (SPSS Inc.,
Chicago, IL, USA). Rates were expressed as percentages and
compared using the chi-square test. Cardinal data were expressed
as mean ± standard deviation; comparisons among groups were
performed with the t test or a nonparametric test depending on
whether variances were equal. A p value < 0.05 was considered
statistically signiﬁcant. The chi-square test for trend was used to
analyze the application situation of MNT, linear correlation analysis
was used to analyze the relationship between body weight and
OGTT results, and the chi-square testwas used to analyze the impact
of MNT on the course of pregnancy and pregnancy outcomes.
Results
Diagnosis of GDM and acceptance of MNT during 2008e2012
Data on 6350 pregnant women aged 21e44 years (mean age,
27.1 ± 4.7 years) were collected over the period 2008e2012. Their
prepregnant BMI ranged from 18.3 kg/m2 to 30.2 kg/m2 (mean,
23.5 ± 1.5 kg/m2). GDMwas diagnosed among 488 of thesewomen.
This group had a mean age of 30.1 ± 4.1 years (range, 21e44 years),
and their mean prepregnant BMI was 24.7 ± 3.0 kg/m2 (range,
18.4e30.2 kg/m2). The prepregnant BMI of the 5862 pregnant
women with normal OGTT was 23.3 ± 1.2 kg/m2 (range,
18.7e28.4 kg/m2) and their mean age was 26.8 ± 4.6 years (range,
21e44 years). Both differences between the two groups were sta-
tistically signiﬁcant (t ¼ 21.7 and 9.7, respectively; both p < 0.001).
In 2008, 2009, 2010, 2011, and 2012, the prevalence of GDM
among screened pregnant women was 5.7%, 5.5%, 7.9%, 9.0%, and
10.2%, respectively. MNT was respectively provided to 30.3%, 43.1%,
66.7%, 69.9%, and 80.7% of the women, indicating a statistically
signiﬁcant increasing trend (c2 trend ¼ 8.19, p < 0.01; see Table 1).
Correlation between BMI and OGTT test results
Among the standard outcomes of the OGTT test, FBG and 1hBG
were signiﬁcantly correlated to body weight gain since the time of
diagnosis (both correlation coefﬁcients ¼ 0.996; p < 0.01). The
2hBG level was correlated to prepregnant body weight,Table 1
Proportion of GDM diagnoses among pregnant women and uptake of MNT for GDM
from 2008 to 2012.
Year GDM diagnosis MNT attendance
N Positive (%) Negative (%) N Uptake (%) No uptake (%)
2008 1157 66 (5.70) 1091 (94.30) 66 20 (30.30) 46 (69.70)
2009 1312 72 (5.49) 1240 (94.51) 72 31 (43.06) 41 (56.94)
2010 1295 102 (7.88) 1193 (92.12) 102 68 (66.67) 34 (33.33)
2011 1259 113 (8.98) 1033 (91.02) 113 79 (69.91) 34 (30.09)
2012 1327 135 (10.17) 1192 (89.83) 135 109 (80.74) 26 (19.26)
total 6350 488 (7.69) 5862 (92.31) 488 307 (62.91) 181 (37.09)
c2trend 1.48 8.19
p 0.139 <0.01
Chi-square test for trend.
GDM ¼ gestational diabetes mellitus; MNT ¼ medical nutrition therapy.prepregnant BMI, and body weight at the time of diagnosis (cor-
relation coefﬁcients ¼ 0.788, 0.854, and 0.785, respectively; all
p < 0.01). A negative correlation was observed between 2hBG and
body weight gain in the early stage of pregnancy (correlation
coefﬁcient 0.119; p < 0.01; Table 2).
Baseline characteristics of women diagnosed with GDM
Among the 488 pregnant women with GDM, 307 (62.9%)
women received MNT. Table 3 shows the characteristics of the
participants. There were no statistical differences observed be-
tween the MNT group and the non-MNT group in age, education
level, occupation, monthly household income, pregnancy BMI,
OGTT results, and gestational weeks and body weight of GDM
diagnosis.
Impact of MNT on body weight change and blood glucose during
pregnancy
The body weights of women from the two groups in the six time
points were shown in Figure 1. The average body weight gain from
the date of GDM diagnosis until 32 weeks gestational age was
1.2 ± 0.2 kg (range, 0.9e1.7 kg) among women accepting MNT,
higher than that in the group of pregnantwomennot receivingMNT
(0.1 ± 1.5 kg; range, 2.0 to 2.0 kg), t ¼ 14.720 (p < 0.001). The
mean body weight gain of the group of pregnant women receiving
MNT from the 32nd week to 36th week of pregnancy and from the
37th week of pregnancy to delivery were both 1.2 ± 0.2 kg (range,
0.9e1.7 kg), lower than that of the group not receiving MNT, where
values of 2.9 ± 0.4 kg (range, 2.5e4.3 kg) and 2.3 ± 0.4 kg (range,
1.8e3.4 kg) were recorded. Both differences were statistically sig-
niﬁcant (t ¼ 64.634 and 42.392, respectively; both p < 0.001.
The FBG, 1hBG, and 2hBG of the two groups of pregnant women
at the time of diagnosis were not statistically signiﬁcantly different.
The FBG and 2hBG of the group of pregnant women receiving MNT
in the 28th, 32nd, and 36th weeks of pregnancy and at delivery were
lower compared with the group not receiving MNT (all p < 0.001;
Figure 2).
Impact of MNT on pregnancy complications and pregnancy
outcomes
The insulin usage, incidence of amniotic ﬂuid abnormalities, rate
of delivery by cesarean section, and frequency of fetal macrosomia
were all lower in the group of pregnant women receiving MNT
compared with the group not receiving MNT (all p < 0.05). No
difference was found between the two groups with regard to
gestational hypertension, vulvovaginal candidiasis, preterm birth,Table 2
Linear correlation analysis between body weight and OGTT results (N ¼ 488).






Prepregnancy body weight (kg) 0.086 0.085 0.788**
Prepregnancy BMI (kg/m2) 0.087 0.090* 0.854**
Body weight when diagnosed (kg) 0.083 0.084 0.785**
Gain in body weight when
diagnosed with GDM (kg)
0.996** 0.996** 0.022
Gain in body weight at 12 wk
gestation (kg)
0.034 0.039 0.119**
Linear correlation analysis: *p < 0.05; **p < 0.01.
1hBG ¼ 1-hour blood glucose; 2hBG ¼ 2-hour blood glucose; BMI ¼ body mass
index; FPG ¼ fasting plasma glucose; GDM ¼ gestational diabetes mellitus;
OGTT ¼ oral glucose tolerance test.
Table 3
Baseline characteristics of participants (N ¼ 488).
Variables Statistics MNT group (n ¼ 307) Non-MNT group (n ¼ 181) p
Age (y) Mean ± SD 32.0 ± 4.3 31.6 ± 4.3 0.267a
Range 21e44 21e41
Education level, n (%) High 233 (75.90) 149 (82.32) 0.230b
Middle 45 (14.66) 18 (9.94)
low 29 (9.45) 14 (7.73)
Occupation, n (%) Mental 169 (55.05) 103 (56.91) 0.909b
Manual 53 (17.26) 29 (16.02)
Home 85 (27.69) 49 (27.07)
Household monthly income, n (%) <2500 RMB 32 (10.42) 13 (7.18) 0.232b
2500 RMB 275 (89.58) 168 (92.82)
Pregnancy status
BMI (kg/m2) Mean ± SD 25.9 ± 4.4 25.5 ± 4.3 0.361a
Range 18.4e33.7 18.4e33.3
Body weight (kg) Mean ± SD 66.2 ± 12.7 65.2 ± 12.4 0.402a
Range 41.1e96.6 43.1e96.6
Gestational weeks of GDM diagnosis Mean ± SD 25.0 ± 1.3 25.2 ± 1.4 0.454c
Range 24e28 24e28
OGTT results
FPG (mmol/L) Mean ± SD 7.54 ± 1.42 7.62 ± 1.48 0.549a
Range 4.80e10.37 4.66e10.13
1hBG (mmol/L) Mean ± SD 13.05 ± 1.92 13.15 ± 2.03 0.555a
Range 10.00e17.13 10.10e16.67
2hBG (mmol/L) Mean ± SD 10.16 ± 1.30 10.03 ± 1.12 0.265a
Range 8.50e14.42 8.20e13.93
Body weight of GDM diagnosis Mean ± SD 75.7 ± 12.7 74.8 ± 12.3 0.460a
Range 48.9e107.7 53.0e107.3
Weight gain of GDM diagnosis Mean ± SD 9.5 ± 2.1 9.6 ± 2.2 0. 562a
Range 6.0e13.7 6.2e13.5
1hBG ¼ 1-hour blood glucose; 2hBG ¼ 2-hour blood glucose; BMI ¼ body mass index; FPG ¼ fasting plasma glucose; GDM ¼ gestational diabetes mellitus; MNT ¼ medical
nutrition therapy; OGTT ¼ oral glucose tolerance test; SD ¼ standard deviation.
a Student t test.
b Chi-square test.
c ManneWhitney test.
Figure 1. Weight change of pregnant women with GDM. * p < 0.05, weight between the two groups. GDM ¼ gestational diabetes mellitus; MNT ¼ medical nutrition therapy.
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p > 0.05; Table 4).
Impact of MNT on postpartum infant feeding
The rate of exclusive breastfeeding within 4 months after de-
livery was 54.4% among women receiving MNT, higher than that in
the group not receiving MNT (29.3%, p < 0.05).Impact of MNT on postpartum prognosis
Among the 488 pregnant women with GDM, only 125 women
underwent a 75-g OGTT reexamination within 6e12 weeks after
delivery. Overall, 98 women underwent a 75-g OGTT reexamination
test within 6 months since delivery, and 265 women underwent
the 75-g OGTT reexamination within 12 months since delivery.
Overall, 92.2% of the group of pregnant women receiving MNT had
Table 4
Impact of MNT on the course of pregnancy and pregnancy outcomes (N ¼ 488).
Group MNT (307) Non-MNT (181) c2 p
PIH Yes 23 (7.49) 12 (6.63) 0.13 0.72
No 284 (92.51) 169 (93.37)
VC Yes 7 (2.28) 4 (2.21) 0.003 0.96
No 300 (97.72) 177 (97.79)
Insulin Yes 63 (20.25) 77 (42.54) 26.99 <0.001
No 244 (79.48) 104 (57.46)
Abnormal
amniotic ﬂuid
Yes 31 (10.10) 33 (18.23) 6.61 0.01
No 276 (89.90) 148 (81.77)
Premature birth Yes 5 (1.63) 4 (2.21) 0.21 0.65
No 302 (98.37) 177 (97.79)
PPROM Yes 25 (8.14) 24 (13.26) 3.30 0.07
No 282 (91.86) 157 (86.74)
Cesarean section Yes 106 (34.53) 116 (64.09) 40.13 <0.001
No 201 (65.47) 15 (8.29)
Macrosomia Yes 30 (9.77) 50 (27.62) 26.48 <0.001
No 277 (90.23) 131 (72.38)
Neonates
hypoglycemia
Yes 7 (2.28) 9 (4.97) 2.60 0.11
No 300 (97.72) 172 (10.61)
MNT ¼ medical nutrition therapy; PIH ¼ pregnancy induced hypertension syn-
drome; PPROM ¼ preterm premature rupture of the membranes; VC ¼ vaginal
candidiasis.
Figure 2. Changes in blood glucose of pregnant women with GDM. * p < 0.001, FPG between the two groups. ** p < 0.001, 2hBG between the two groups. 2hBG ¼ 2-hour blood
glucose; FPG ¼ fasting plasma glucose; GDM ¼ gestational diabetes mellitus; MNT ¼ medical nutrition therapy.
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receiving MNT (66.30%; p < 0.001).
Discussion
GDM is one of the most common medical complications during
pregnancy. Given both the constant increase in the prevalence of
obesity and gestational age and the less stringent diagnostic criteria
for GDM, the incidence of GDM has steadily increased in recent
years [18]. BMI is an important indicator of the nutritional status,
and a higher prepregnant BMI is a risk factor for metabolic abnor-
malities during pregnancy, amongwhich GDM is themost common
[19]. A study by Chan [20] and Ryan [21] also found that pregnant
womenwith excessive body weight gain during pregnancy were at
an elevated risk of developing GDM, and that there is a strong
correlation between excessive body weight gain during pregnancy
and the maternal blood glucose level. Prenatal care for GDM in-
cludes MNT, exercise, medication, and blood glucose monitoring.
MNT is essential for other treatments, and “individualized nutrition
therapy” by nutrition professionals is recommended for pregnant
women with GDM. The Evidence-Based Nutrition Practice Guide-
lines for GDM developed by the American Dietetic Association in2008 provides the evidentiary basis for nutritional management of
pregnant women with GDM [22]. The China Medical Nutrition
Therapy Guideline for Diabetes 2010, the ﬁrst guideline for diabetes
management in China, is a normative guideline for MNT. Pregnant
women who are diagnosed to have GDM in the gestational
screening should receive MNT as early as possible to reduce the
burden of the pancreas, improve the sensitivity of target tissues to
insulin, and enhance its binding with insulin to maintain blood
glucose at normal levels, while ensuring the physiological needs of
pregnant women and the normal growth and development of the
fetuses [23e25].
The incidence of GDM in the hospital where the study was
performed has reached 10.2% in the review last year, which was
close to the estimate made by Shang and Lin [13]. Globally, the
estimated prevalence ranges from 1% to 14% of all pregnancies,
depending on the population being studied and the diagnostic tests
used. Approximately 6e7% of all pregnancies are complicated by
GDM in China, translating into 1,200,000e1,400,000 cases annu-
ally. Once GDM has been diagnosed, women frequently go on an
overly strict diet owing to a lack of awareness of GDM treatment
options and a common fear of insulin. This often leads to inade-
quate energy intake, negative body weight growth, and other un-
desirable outcomes that are not conducive to fetal growth and
development. As a consequence of insufﬁcient body weight gain,
these women then commonly increase food intake in the third
trimester, resulting in adverse pregnancy outcomes. Our study also
found that pregnant women who did not receive MNT temporarily
had negative body weight growth after being diagnosed with GDM,
followed by their body weight rebounding. Among them, 42.5%
used insulin to control blood glucose levels. The essence of the
“individualized treatment” advocated by MNT is to adjust energy
intake to individual needs and reasonably arrange meals based on
body weight and dynamic changes in blood glucose during preg-
nancy so as to balance blood glucose and ensure the safety and
good health of the mother and the fetus [26e28]. Our study also
found that reasonable and effectiveMNTcan control and steady the
body weight gain each week from diagnosis to delivery. The mean
weekly weight gain of the group of 307 pregnant women receiving
MNTwas controlled within 0.3 ± 0.1 kg; meanwhile, in the group of
181 pregnant women not receiving MNT, 86 had a signiﬁcant
negative body weight growth from the date of diagnosis to the 32nd
week, 26 had zero weight growth, and 69 had continued weight
growth after the 32nd week, with an mean weight gain of
0.8 ± 0.2 kg/wk, exceeding the weight gain requirements pre-
scribed by the guideline (0.3e0.5 kg/wk).
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pregnancy outcomes [29]. According to our results, MNT can
effectively reduce the usage of insulin during pregnancy and the
incidence of amniotic ﬂuid abnormalities, cesarean delivery, and
huge fetus, which is consistent with previous reports [30]. Women
of childbearing age should be prepared to adjust prepregnant
weight, and perinatal care physicians should tighten the manage-
ment of their weight gain during pregnancy. Enhanced and indi-
vidualized nutritional guidance for high-risk groups such as
pregnant women who are underweight or overweight prior to
pregnancy is key to reducing the risk of adverse pregnancy out-
comes. MNT, as a special lifestyle intervention, is easy to under-
stand but difﬁcult to implement. This is because unlike a general
medication or surgical treatment, nutrition therapy needs the
involvement of both physicians and patients and timely adjustment
based on the effect of its implementation [31,32].
China has recently raised the nutritional requirements of preg-
nant women to the policy level. The following suggestions have also
been made: (1) hospitals should offer outpatient pregnancy nutri-
tion surveillance as early nutrition interventions in pregnancy and
personalized nutrition therapy can optimize diets; (2) hospitals
should routinely conduct pregnancy nutrition surveillance; (3)
extensive nutrition and health education should be offered in
hospitals and communities, such as “fetal university,” “mom class,”
and “Mummy Kitchen,” to actively promote adequate nutrition and
health awareness as well as self-management capabilities for
pregnant women and their families, guide their food choices, and
support reasonable weight management. In the case of the hospital
where the present study had been conducted, pregnancy outpa-
tient services and “mom classes” had been established in 2008 to
offer individual and group education for women with GDM. Some
problems arose in practice, including a lack of dietitians and
appropriate outpatient units, an underappreciation of the time
needs of individualized therapy, and little understanding and
appreciation of MNT by pregnant women and their families, which
means that some pregnant women with GDM do not seek medical
treatment at all or receive inappropriate care, resulting in 37.1% of
all pregnant women with GDM not receiving MNT during the 5-
year study period.
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